Pharmaceutical Market Europe • December 2024 • 5

CONTENTS

December 2024

NEWS & COLUMNS


6-7 NEWS
Merck and LaNova in $3.2bn deal; AbbVie to acquire Aliada for $1.4bn

8-9 NEWS
UCB's results for Alzheimer’s candidate; J&J’s Balversa approved by MHRA for bladder cancer

10-11 DERMATOLOGY NEWS
FDA approves Journey Medical’s Emrosi; LEO’s Anzupgo approved by MHRA

12 DARWIN'S MEDICINE
You get what you like, not what you need

13 THE ROLE OF CAREGIVERS
Caregivers often play an integral role during interactions with medical professionals

14 INNOVATIVE IMPACT
Shaping tomorrow with strategic foresight in early commercialisation

15 PRO BONO WORK IN PHARMA
Making a difference beyond the bottom line

FEATURES


16-18 TACKLING THE GROWING BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE UK
Iona Everson from PMGroup spoke to John Forni, Country Medical Director at Sanofi UK & Ireland, about the escalating challenges of treating chronic obstructive pulmonary disease (COPD) in the UK and how the government, NHS and industry can work together to tackle this

20-21 TAKING THE CAMPAIGN
AGAINST CANCER INTO THE CLOUD

Technology’s ability to accelerate the pace of innovation while reducing the cost is changing the dynamic of the struggle against cancer in myriad ways

24-26 LAUNCHING A NOVEL
DRUG TREATMENT IN JAPAN

As the world’s third largest pharmaceutical market, Japan accounted for approximately 6% of the $1.5tn in global pharmaceutical sales in 2022. However, the path to market access in Japan is complex and is about more than just pricing and reimbursement

COMMUNIQUE
MARKETING & COMMS


30-35 PMEA 2024:
A CELEBRATION OF EXCELLENCE
IN PHARMACEUTICAL MARKETING

The PMEA programme rewards work that delivers clearly identifiable benefits for patients in global, regional and local markets. This year’s Awards, held at the Sheraton Grand in London, included 17 categories

38-40 THE NEED FOR A HUMAN
TOUCH IN AN AI WORLD

AI is shooting for the moon and the stars but the real benefits come from anchoring it to the human voice

41-43 BRAND STRATEGY –
REVIEWING WHAT YOU’VE LEARNT

Presenting your brand strategy for review by your most senior colleagues is a big deal, both professionally and personally. Preparing good answers to the investable challenges is important to both your brand team and to your own career. This series of four articles helps you answer the four most important of them

CAREERS & RECRUITMENT


44-46 APPOINTMENTS
Changes at Pfizer, Novartis and the EMA

36 PHARMA MARKETING JOBS
Visit our new website for all
your recruiting needs!